Trans-Tenon’s retrobulbar triamcinolone infusion for the treatment of uveitis
- Correspondence to: Annabelle A Okada, MD, Department of Ophthalmology, Kyorin University School of Medicine, 6-20-2 Shinkawa, Mitaka, Tokyo 181–8611 Japan; aokada{at}po.iijnet.or.jp
- Accepted 20 December 2002
Abstract
Aim: To assess efficacy and complications of trans-Tenon’s retrobulbar infusion of triamcinolone acetonide for posterior uveitic inflammation.
Methods: Non-randomised, uncontrolled, retrospective study of 51 eyes of 37 patients who underwent triamcinolone infusion for vitritis, cystoid macular oedema (CMO), or posterior retinal vasculitis using a long blunt cannula via an incision made through conjunctiva and Tenon’s capsule.
Results: Overall clinical efficacy was 86%; 96% for vitritis, 82% for CMO, and 33% for posterior retinal vasculitis. Mean visual acuity improved within 1 month after triamcinolone infusion (p <0.05). Cataract progression and intraocular pressure elevation were observed in 31% and 27% of eyes, respectively.
Conclusion: Trans-Tenon’s retrobulbar triamcinolone infusion may be a safe and effective treatment for posterior uveitic inflammation.
